Skip to main content
NUTRITIONAL GROWTH SOLUTIONS LTD logo

NUTRITIONAL GROWTH SOLUTIONS LTD — Investor Relations & Filings

Ticker · NGS ISIN · IL0011681116 ASX Manufacturing
Filings indexed 356 across all filing types
Latest filing 2024-04-25 Capital/Financing Update
Country AU Australia
Listing ASX NGS

About NUTRITIONAL GROWTH SOLUTIONS LTD

https://ngsolutions.co/

Nutritional Growth Solutions Ltd. specializes in the development and commercialization of clinically-proven nutritional supplements designed to support the growth and development of children. The company’s core product portfolio, marketed under the Healthy Heights brand, features protein shakes and nutritional powders formulated with a specific balance of macronutrients and micronutrients. These formulations are based on extensive clinical research conducted at the Schneider Children’s Medical Center and are intended for children who are short or lean. The company focuses on providing scientifically validated solutions to address nutritional gaps and promote healthy physical development. Its unique value proposition is centered on peer-reviewed clinical studies demonstrating the efficacy of its products in increasing height and weight without adversely affecting body mass index.

Recent filings

Filing Released Lang Actions
Binding Commitments for $2million Capital Raise 5 pages 230.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 26 April 2024 regarding a capital raise by Nutritional Growth Solutions Limited. It details binding commitments for a loan notes placement and a share placement, including terms, use of proceeds, and an indicative timetable for shareholder approval and issuance. The content focuses on fundraising activities, capital structure changes, and related shareholder approvals. There are no financial statements or comprehensive financial performance data presented, so it is not an Annual Report or Interim Report. It is not a regulatory certification or voting result announcement. The primary purpose is to update investors on the company's capital raising activities. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2024-04-25 English
Proposed issue of securities - NGS 5 pages 17.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a placement or other type of securities issue by Nutritional Growth Solutions Ltd. It includes specifics such as the number of securities to be issued, issue price, dates, and conditions related to the placement. The content focuses on the announcement of a capital raising event rather than financial results, management changes, or regulatory filings. The document length is 5764 characters, which is sufficient to contain substantive details about the capital issuance. Therefore, this document fits the category of a Capital/Financing Update (CAP).
2024-04-25 English
Proposed issue of securities - NGS 4 pages 16.0KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed placement or other type of securities issue by Nutritional Growth Solutions Ltd. It includes specifics such as the number of securities, issue date, consideration (strategic advisory services), and compliance with ASX listing rules. This is a formal announcement of a capital raising or securities issuance event. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. The content aligns with a Capital/Financing Update, which covers company fundraising or capital structure changes.
2024-04-25 English
Annual Report to shareholders 46 pages 2.0MB
Regulatory Filings
2024-03-27 English
Appendix 4G and Corporate Governance Statement 23 pages 760.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a completed Appendix 4G form, which is a key to where corporate governance disclosures can be found and serves as a verification tool for compliance with ASX Listing Rule 4.10.3. The document explicitly states it is not a substitute for the corporate governance statement itself but is lodged alongside the annual report. It contains no financial statements or substantive financial data but rather governance compliance checklists and references to where the corporate governance statement can be found (on the website). This matches the description of a Regulatory Filing (RNS) as it is a regulatory compliance document that does not fit other categories such as Annual Report or Governance Information (CGR) because it is a form lodged with ASX to confirm governance disclosures rather than the governance report itself. The document length (15,000 characters) is substantial but the content is a regulatory compliance form, not a full report or presentation.
2024-03-27 English
Preliminary Final Report 6 pages 427.6KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E For the year ended 31 December 2023' and is an ASX announcement. It contains detailed financial statements including consolidated statements of profit or loss, financial position, cash flows, and changes in equity for the full fiscal year ended December 31, 2023. It also includes commentary on results, capital raising activities, and notes on audit status. The document is 13,802 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or summary. The presence of full financial statements and detailed financial commentary for a full fiscal year indicates this is a comprehensive annual financial report. The document also states that the accounts are in the process of being audited and that the annual report containing the audit report will be provided later, which suggests this is a preliminary annual report or financial results announcement. Given the detailed financial data and the nature of the document, it fits best under the category of an Interim / Quarterly Report (IR) or Annual Report (10-K). However, since it is for the full year ended December 31, 2023, and includes comprehensive financial statements, it aligns more with an Annual Report (10-K) equivalent filing. The document is an Appendix 4E, which in ASX terminology is a preliminary final report for the full year, often considered an annual report equivalent. Therefore, the best classification is Annual Report (10-K). FY 2023
2024-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.